BCVA gains of +5.5 letters at 24 months in Cohort 4 patients
BCVA gains of +7.4 letters among Cohort 4 patients with extensive OpRegen bleb coverage of the GA lesion
Maintenance or increases.
Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that 24 month results from patients enrolled in.
Retina Consultants of America Continues Growth by Adding Pacific Northwest Retina prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Anchor Health Properties Commences Third Quarter with Four Off Market Class A MOB Acquisitions Totaling more than $100M Across the US prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.